Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain.

María Antonia Pastor-Nieto,P Checa‐Díaz,Patricia González-Muñoz,Adriana Martín Fuentes,Aranzazu Vergara-Sánchez,Consuelo Sánchez-Herreros,E. Jiménez-Blázquez,R Cabana‐Navia,J Martínez‐Mariscal,Pablo Cobo‐Rodríguez,Iván Checa‐Recio,María-Elena Gatica-Ortega,M. Torralba,E. de Eusebio Murillo

Prior treatment with immunosuppressants among COVID-19 inpatients at one hospital in Spain.

2020

María Antonia Pastor-Nieto
P Checa‐Díaz
Patricia González-Muñoz
Adriana Martín Fuentes
Aranzazu Vergara-Sánchez
Consuelo Sánchez-Herreros
E. Jiménez-Blázquez
R Cabana‐Navia
J Martínez‐Mariscal
Pablo Cobo‐Rodríguez
Iván Checa‐Recio
María-Elena Gatica-Ortega
M. Torralba
E. de Eusebio Murillo

Vulnerability to coronavirus disease 2019 (COVID-19) in patients with cardiovascular risk factors is well known. However, the prognostic influence of immunosuppressive drugs or their ability to counteract the cytokine storm involving critically-ill patients are uncertain. The scarce related literature mainly involves transplantation.

Keywords:

Dermatology
Cytokine storm
cyclosporin a
Coronavirus disease 2019
Intensive care medicine
prior treatment
in patient
Immunosuppression
Medicine
Transplantation
cardiovascular risk factors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations